Terminal olefins frequently are transformed by metabolic processes to chemically-reactive, short-lived metabolites which may cause toxic effects through covalent interactions with cellular macromolecules. Examples of such toxicities may be found in the mechanism-based inactivation of several enzymes involved in the beta-oxidation of fatty acids and in the oxidation of endogenous and exogenous substances by cytochromes P450. In addition, many terminal olefins are genotoxic due to alkylation of DNA by reactive metabolites thereof. To date, most studies on terminal olefins have focused on preformed unsaturated compounds of pharmaceutical or environmental importance. However, there is now a growing body of evidence which indicates that certain olefins can themselves be formed by metabolic desaturation of aliphatic substrates, and that the responsible enzyme system is the cytochrome P450-dependent mixed function oxidase. A case in point is 4-ene-VPA, a potent hepatotoxic metabolite of the antiepileptic drug valproic acid (VPA) which is formed from the parent drug by the action of p450. In light of these recent observations, it becomes important to understand, at the molecular level, which factors control the conversion of compounds such as aliphatic carboxylic acids to their corresponding alkenes, and how the regiochemistry of the desaturation process is determined. (Recent work has shown that the isomeric 3-ene-VPA also is formed from VPA by P450). In particular, there is a need for basic information on the mechanism by which p450 catalyzes these novel desaturation reactions (which accompany the more traditional oxygenation events). The overall goal of the proposed research is to define the chemical and enzymatic mechanisms of P450-dependent desaturation reactions. This will be accomplished using VPA and the endogenous molecules, lauric acid and palmitic acid, as model substrates. A comprehensive series of studies is proposed to identify specific isoforms of animal and human liver P450 responsible for terminal and sub-terminal desaturation of these substrates and to elucidate the underlying reaction mechanisms.
The specific aims of the research are as follows; (1) To identify and purify specific rat liver forms of p450 responsible for 3-ene-VPA formation; (2) To identify the rate-limiting step(s) in the desaturation of VPA to 3- and 4-ene-VPA; (3) To establish that P450 is responsible for the terminal desaturation of long-chain monocarboxylic acids; (4) To correlate relative w:w-2 fatty acid hydroxylase activities with terminal:subterminal olefin formation using cDNA-expressed forms of human P450; and (5) To probe the possible involvement of carbocations as intermediates in P450-mediated fatty acid desaturation. The fundamental knowledge gained from these investigations will be employed to construct a unified model for P450-catalyzed oxidation reactions, and will provide a working framework for the prediction of the oxidized metabolites expected to arise from catalysis by this important enzyme system. GRANTS=R43GM50044 Energy-dispersive x-ray detectors (EDDs) are heavily used in biological research at synchrotron radiation facilities, particularly for absorption spectroscopy in fluorescence mode on dilute samples. Current research relies on semiconductor EDD spectrometers, which typically become pileup limited at fairly low count rates for the biologically important elements P, S and C1, due to the long electronic processing times required to obtain acceptable energy resolution for these soft x-rays. The present research proposes to develop an alternative detector based on electron multiplication technology. Although electron multipliers are very low noise amplifiers and are capable of very high counting rates, presently available scintillator-photomultiplier (PMT) detectors are not competitive with semiconductor EDDs due to their extremely poor energy resolution, which arises from statistical fluctuations in the inefficient conversion between x-rays and electrons for amplification by the PMT. We are therefore proposing to investigate a novel technology for increasing the efficiency of the conversion process. Initial calculations suggest that if this conversion process can be made to work close to its theoretical efficiency, it would be possible to construct detectors having energy resolution superior to semiconductor EDDs for energies below 4 ke V and capable of throughputs in excess of 106 counts/sec. Because no complex electronics would be required to process these detectors' output pulses, they would also be relatively inexpensive to array for even higher countrate capability.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
3R01GM049054-04S1
Application #
2753918
Study Section
Pharmacology A Study Section (PHRA)
Project Start
1994-04-01
Project End
1998-12-31
Budget Start
1997-04-01
Budget End
1998-12-31
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Washington
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Hsu, Mei-Hui; Baer, Brian R; Rettie, Allan E et al. (2017) The Crystal Structure of Cytochrome P450 4B1 (CYP4B1) Monooxygenase Complexed with Octane Discloses Several Structural Adaptations for ?-Hydroxylation. J Biol Chem 292:5610-5621
Parkinson, Oliver T; Teitelbaum, Aaron M; Whittington, Dale et al. (2016) Species Differences in Microsomal Oxidation and Glucuronidation of 4-Ipomeanol: Relationship to Target Organ Toxicity. Drug Metab Dispos 44:1598-602
Schmidt, Eva M; Wiek, Constanze; Parkinson, Oliver T et al. (2015) Characterization of an Additional Splice Acceptor Site Introduced into CYP4B1 in Hominoidae during Evolution. PLoS One 10:e0137110
Wiek, Constanze; Schmidt, Eva M; Roellecke, Katharina et al. (2015) Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol. Biochem J 465:103-14
Lockhart, Catherine M; Nakano, Mariko; Rettie, Allan E et al. (2014) Generation and characterization of a murine model of Bietti crystalline dystrophy. Invest Ophthalmol Vis Sci 55:5572-81
Nakano, Mariko; Lockhart, Catherine M; Kelly, Edward J et al. (2014) Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition. Drug Metab Rev 46:247-60
Edson, Katheryne Z; Rettie, Allan E (2013) CYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ?-hydroxylase activities. Curr Top Med Chem 13:1429-40
Parkinson, Oliver T; Liggitt, H Denny; Rettie, Allan E et al. (2013) Generation and characterization of a Cyp4b1 null mouse and the role of CYP4B1 in the activation and toxicity of Ipomeanol. Toxicol Sci 134:243-50
Nakano, Mariko; Kelly, Edward J; Wiek, Constanze et al. (2012) CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ?-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant. Mol Pharmacol 82:679-86
Parkinson, O T; Kelly, E J; Bezabih, E et al. (2012) Bioactivation of 4-Ipomeanol by a CYP4B enzyme in bovine lung and inhibition by HET0016. J Vet Pharmacol Ther 35:402-5

Showing the most recent 10 out of 13 publications